๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-05
Trial ID
NCT00085462
This is a study to investigate the efficacy and safety of an infusion of IO...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-07-20
Trial ID
NCT05361174
Treatments Being Tested
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2016-12
Trial ID
NCT02926053
The subject of this study is the adoptive transfer of selected autologous t...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Start Date
2023-06-19
Trial ID
NCT05902520
Treatments Being Tested
To determine whether special tumor fighting cells that is taken from partic...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2020-10-07
Trial ID
NCT03991741
Treatments Being Tested
The purpose of this first in human study is to evaluate the feasibility, sa...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2022-11-22
Trial ID
NCT05628883
Treatments Being Tested
This is an open-label, phase 1 trial evaluating the safety of oncolytic ade...
Status
Active Not Recruiting
Location
National Center for Cancer Immune Therapy Herlev Hospital, Copenhagen University
Start Date
2025-06-25
Trial ID
NCT06961786
Treatments Being Tested